Technologies Under Review

UConn R & D is currently evaluating several technologies invented by UConn professors and faculty. These include:

Treatment for Cardiac Failure

Dr. Bruce Liang, Director of the Pat and Jim Calhoun Cardiology Center, has identified a new target and class of agents to treat skeletal muscle ischemia and reperfusion injuries, as well as injuries from physical exertion. UConn R & D is evaluating the use of these agents as a treatment for cardiac hypertrophy and failure.

Applications for Photoactive Proteins

Dr. Robert Birge, Harold S. Schwenk Distinguished Professor of Biophysical Chemistry, is researching genetically engineered bacteriorhodopsin. Bacteriorhodopsin proteins generate an electrical pulse when photo-activated. The Birge Lab manufactures variants of the proteins and screens them to optimize their photochemical properties. UConn R & D is exploring the use of these proteins in a variety of applications, including solar photovoltaics, 3-D memory storage, and artificial retinas.

Contact UConn R & D for further information on these technologies, or to inquire about other technologies under review.